James Frederick Ronk, MD | |
6465 S Yale Ave, Suite 215, Tulsa, OK 74136-7823 | |
(918) 492-8455 | |
(918) 494-0102 |
Full Name | James Frederick Ronk |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 36 Years |
Location | 6465 S Yale Ave, Tulsa, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467502005 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 18623 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tulsa Eye Associates, Inc., A Professional Corporation | 9931274602 | 2 |
News Archive
Adamis Pharmaceuticals Corporation (OTCBB: ADMP), announced today that it has entered into a definitive merger agreement providing for the acquisition of La Jolla Pharmaceutical Company by Adamis.
As parents, physicians and policymakers look for ways to curb childhood obesity, they may need to look no further than a child's own backyard.
Demonstrating the fortitude to address a challenging healthcare environment, president and C.E.O. Steven D. Sonenreich has led Mount Sinai Medical Center to financial stability and successfully reinforced its image as a healthcare leader. The most recent audit posted on March 26 reports nearly $14 million in profit for 2009.
"It sounds like a new Apple product, but IPAB is actually a controversial board at the heart of a highly charged battle over Medicare, the federal health program for the elderly and disabled".
Aeterna Zentaris Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration ("FDA") for its ghrelin agonist, macimorelin acetate (AEZS-130).
› Verified 7 days ago
Entity Name | Tulsa Eye Associates, Inc., A Professional Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740449818 PECOS PAC ID: 9931274602 Enrollment ID: O20080814000192 |
News Archive
Adamis Pharmaceuticals Corporation (OTCBB: ADMP), announced today that it has entered into a definitive merger agreement providing for the acquisition of La Jolla Pharmaceutical Company by Adamis.
As parents, physicians and policymakers look for ways to curb childhood obesity, they may need to look no further than a child's own backyard.
Demonstrating the fortitude to address a challenging healthcare environment, president and C.E.O. Steven D. Sonenreich has led Mount Sinai Medical Center to financial stability and successfully reinforced its image as a healthcare leader. The most recent audit posted on March 26 reports nearly $14 million in profit for 2009.
"It sounds like a new Apple product, but IPAB is actually a controversial board at the heart of a highly charged battle over Medicare, the federal health program for the elderly and disabled".
Aeterna Zentaris Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration ("FDA") for its ghrelin agonist, macimorelin acetate (AEZS-130).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
James Frederick Ronk, MD 6465 S Yale Ave, Suite 215, Tulsa, OK 74136-7823 Ph: (918) 492-8455 | James Frederick Ronk, MD 6465 S Yale Ave, Suite 215, Tulsa, OK 74136-7823 Ph: (918) 492-8455 |
News Archive
Adamis Pharmaceuticals Corporation (OTCBB: ADMP), announced today that it has entered into a definitive merger agreement providing for the acquisition of La Jolla Pharmaceutical Company by Adamis.
As parents, physicians and policymakers look for ways to curb childhood obesity, they may need to look no further than a child's own backyard.
Demonstrating the fortitude to address a challenging healthcare environment, president and C.E.O. Steven D. Sonenreich has led Mount Sinai Medical Center to financial stability and successfully reinforced its image as a healthcare leader. The most recent audit posted on March 26 reports nearly $14 million in profit for 2009.
"It sounds like a new Apple product, but IPAB is actually a controversial board at the heart of a highly charged battle over Medicare, the federal health program for the elderly and disabled".
Aeterna Zentaris Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration ("FDA") for its ghrelin agonist, macimorelin acetate (AEZS-130).
› Verified 7 days ago
Mark Justin Weiss, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1717 S Utica Ave, Ste 107, Tulsa, OK 74104 Phone: 918-742-2428 Fax: 918-742-8435 | |
Anthony Economou, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2865 E Skelly Dr Ste 250, Tulsa, OK 74105 Phone: 918-317-0022 Fax: 855-327-9828 | |
Dr. Justin Parschauer, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6600 S Yale Ave, Suite 800, Tulsa, OK 74136 Phone: 918-491-3900 | |
Dr. Zeb Linston Brister, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3906 S Peoria Ave, Tulsa, OK 74105 Phone: 918-585-1523 Fax: 918-584-5520 | |
John Thomas Romano, D.O. Ophthalmology Medicare: Medicare Enrolled Practice Location: 4444 S Harvard Ave, Ste 300, Tulsa, OK 74135 Phone: 918-747-2020 Fax: 918-747-2056 | |
Dr. Bruce Ben Pettigrove, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 6606 S. Yale, #220, Tulsa, OK 74136 Phone: 918-492-4122 Fax: 918-492-7451 | |
Shehzad Y Batliwala, D.O Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10010 E 81st St Ste 100, Tulsa, OK 74133 Phone: 918-250-2020 |